New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January
Oncology December 28,2023
Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January
Oncology December 28,2023
New hope for kidney cancer treatment using existing drugs

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena
Oncology December 28,2023
New hope for kidney cancer treatment using existing drugs

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena
Oncology December 28,2023
Finding molecular secrets hidden in premature aging diseases and cancer using AI

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in
Oncology December 28,2023
Finding molecular secrets hidden in premature aging diseases and cancer using AI

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in
Oncology December 28,2023
Using spatial single-cell transcriptomics to visualize diffuse midline glioma

Using spatial single-cell transcriptomics to visualize diffuse midline glioma

byChildren's Hospital BostonH3-K27M DMG cohort profiled by single-cell multi-omics. a, Schematic of the workflow. b, Clinico-molecular cohort characteristics. The upper legend bars depict th
Oncology December 28,2023
Using spatial single-cell transcriptomics to visualize diffuse midline glioma

Using spatial single-cell transcriptomics to visualize diffuse midline glioma

byChildren's Hospital BostonH3-K27M DMG cohort profiled by single-cell multi-omics. a, Schematic of the workflow. b, Clinico-molecular cohort characteristics. The upper legend bars depict th
Oncology December 28,2023
Tackling resistance to HIF2 drugs with an RNA-based therapy

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca
Oncology December 28,2023
Tackling resistance to HIF2 drugs with an RNA-based therapy

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca
Oncology December 28,2023
Fighting cancer on Earth and in space using high-energy protons

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph
Oncology December 28,2023
Fighting cancer on Earth and in space using high-energy protons

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph
Oncology December 28,2023
Using low-intensity continuous ultrasound to inhibit cancer cell migration

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d
Oncology December 28,2023
Using low-intensity continuous ultrasound to inhibit cancer cell migration

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d
Oncology December 28,2023
Using single-cell sequencing to reveal processes involved in ovarian and breast cancers

Using single-cell sequencing to reveal processes involved in ovarian and breast cancers

by Bob Yirka , Medical XpressStudy overview. Experimental and cohort design. Single-cell genomes, transcriptomes and long-read sequencing libraries were generated from isogenic 184-hTERT cell lines (W
Oncology December 28,2023
Using single-cell sequencing to reveal processes involved in ovarian and breast cancers

Using single-cell sequencing to reveal processes involved in ovarian and breast cancers

by Bob Yirka , Medical XpressStudy overview. Experimental and cohort design. Single-cell genomes, transcriptomes and long-read sequencing libraries were generated from isogenic 184-hTERT cell lines (W
Oncology December 28,2023
Children born after frozen-thawed embryo transfer may face higher cancer risk

Children born after frozen-thawed embryo transfer may face higher cancer risk

byPublic Library of ScienceNordic researchers find that children born after frozen-thawed embryo transfer had a higher cancer risk. Credit: Victoria_Borodinova, Pixabay (CC0, creativecommons.org
Oncology December 28,2023
Children born after frozen-thawed embryo transfer may face higher cancer risk

Children born after frozen-thawed embryo transfer may face higher cancer risk

byPublic Library of ScienceNordic researchers find that children born after frozen-thawed embryo transfer had a higher cancer risk. Credit: Victoria_Borodinova, Pixabay (CC0, creativecommons.org
Oncology December 28,2023
Understanding the role of cancer's circular genome in tumor evolution

Understanding the role of cancer's circular genome in tumor evolution

byQueen Mary, University of LondonOverview of strategies to develop and test rules of ecDNA behavior with mathematical modeling, computer simulations, cell line and patient data. Credit:Na
Oncology December 28,2023
Understanding the role of cancer's circular genome in tumor evolution

Understanding the role of cancer's circular genome in tumor evolution

byQueen Mary, University of LondonOverview of strategies to develop and test rules of ecDNA behavior with mathematical modeling, computer simulations, cell line and patient data. Credit:Na
Oncology December 28,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com